Literature DB >> 33522393

Exosomal miR-487a derived from m2 macrophage promotes the progression of gastric cancer.

Xuefeng Yang1,2, Shuang Cai2, Yue Shu3, Xun Deng2, Yuanwei Zhang2, Nian He2, Lei Wan2, Xu Chen2, Yan Qu2, Shouyang Yu3.   

Abstract

Tumor-associated macrophages contribute to cell growth, development, and metastasis in various cancers. However, the underlying mechanisms of M2 macrophage that modulate the progression of gastric cancer (GC) remain largely unknown. In this study, we detected the ratio of macrophages in GC tissues and found that the proportion of M2 macrophages was increased in GC tissues. We then co-cultured GC cells with M1 and M2 macrophages, respectively, and then assessed cell proliferation and tumorigenicity of GC cells by MTT and colony formation assay. The results indicated that M2 macrophages promoted the proliferation of GC cells, but M1 not. Besides, GW4869, an exosomes inhibitor, reduced the effects induced by M2 macrophage. Then, we isolated and identified exosomes derived from M1 and M2 macrophage, and confirmed that the exosomes could be taken up by GC cells. We demonstrated that M2 macrophage-exosomes could induce the proliferation and tumorigenesis in vitro and in vivo. Moreover, miR-487a was enriched in M2 macrophage-exosomes and further determined that miR-487a exert the functions by targeting TIA1. In conclusion, exosomal miR-487a derived from M2 macrophage promotes the proliferation and tumorigenesis in gastric cancer, and the novel findings might be helpful to the development of novel diagnostic and therapeutic methods in GC.

Entities:  

Keywords:  M2 macrophage; exosome; gastric cancer; microRNA; proliferation; tumorigenesis

Mesh:

Substances:

Year:  2021        PMID: 33522393      PMCID: PMC7894454          DOI: 10.1080/15384101.2021.1878326

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

1.  An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Authors:  Yunyun Liu; Xiaoyu Li; Yuanpei Zhang; Hongxuan Wang; Xiongming Rong; Jialing Peng; Lei He; Ying Peng
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

Review 2.  Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren's syndrome.

Authors:  Antonella Cecchettini; Francesco Finamore; Ilaria Puxeddu; Francesco Ferro; Chiara Baldini
Journal:  Clin Exp Rheumatol       Date:  2019-08-28       Impact factor: 4.473

3.  miR-487a promotes progression of gastric cancer by targeting TIA1.

Authors:  Xuefeng Yang; Mingda Wang; Bohao Lin; Dongjie Yao; Jin Li; Xianchun Tang; Sanhua Li; Yun Liu; Rui Xie; Shouyang Yu
Journal:  Biochimie       Date:  2018-08-23       Impact factor: 4.079

Review 4.  Chemotherapy for advanced gastric cancer.

Authors:  Anna Dorothea Wagner; Nicholas Lx Syn; Markus Moehler; Wilfried Grothe; Wei Peng Yong; Bee-Choo Tai; Jingshan Ho; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

5.  Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages.

Authors:  Dorothée Duluc; Murielle Corvaisier; Simon Blanchard; Laurent Catala; Philippe Descamps; Erick Gamelin; Stéphane Ponsoda; Yves Delneste; Mohamed Hebbar; Pascale Jeannin
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 8.  Exosomes in cancer: small particle, big player.

Authors:  Xu Zhang; Xiao Yuan; Hui Shi; Lijun Wu; Hui Qian; Wenrong Xu
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

9.  Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma.

Authors:  Jing Ma; Min Xu; Minzhi Yin; Jie Hong; Haoyan Chen; Yijin Gao; Chenjie Xie; Nan Shen; Song Gu; Xi Mo
Journal:  Front Oncol       Date:  2019-06-12       Impact factor: 6.244

10.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

View more
  5 in total

1.  An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer.

Authors:  Sharmilla Devi Jayasingam; Marimuthu Citartan; Anani Aila Mat Zin; Timofey S Rozhdestvensky; Thean-Hock Tang; Ewe Seng Ch'ng
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

2.  KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.

Authors:  Anyu Luo; Hanlin Liu; Chen Huang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

3.  Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression.

Authors:  Bo Chen; Deqing Liu; Runjie Chen; Libing Guo; Jianmin Ran
Journal:  Discov Oncol       Date:  2022-07-01

Review 4.  Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications.

Authors:  Jingyao Ye; Xuehong Liu
Journal:  Front Cell Dev Biol       Date:  2022-06-27

Review 5.  Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications.

Authors:  Xiao-Huan Tang; Ting Guo; Xiang-Yu Gao; Xiao-Long Wu; Xiao-Fang Xing; Jia-Fu Ji; Zi-Yu Li
Journal:  Mol Cancer       Date:  2021-07-30       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.